Prevention of ischemic stroke

被引:4
作者
Jesse Weinberger
机构
[1] The Mount Sinai School of Medicine,Department of Neurology
关键词
Warfarin; Ischemic Stroke; Clopidogrel; Transient Ischemic Attack; Ticlopidine;
D O I
10.1007/s11936-002-0019-z
中图分类号
学科分类号
摘要
The primary risk factors for stroke are known, and attention to primary care of these disorders should reduce the incidence of stroke significantly. Control of hypertension, diabetes, and hyperlipidemia have all been shown to reduce the rate of stroke. Identification of potential cardioembolic sources of stroke, particularly atrial fibrillation, can prevent stroke with appropriate application of anticoagulation. Duplex Doppler B-mode sonography can establish the extent of carotid artery disease in patients with cervical bruit or risk factors for atherosclerosis, and indicate which conditions should be managed medically or surgically. Patients with a history suggestive of transient ischemic attacks can also be screened noninvasively with duplex sonography to determine if they have a critical carotid stenosis and require carotid endarterectomy. New advances in platelet antiaggregant therapy with ticlopidine, clopidogrel, and the combination of aspirin with dipyridamole have also reduced the rate of stroke to a greater degree than standard treatment with aspirin. The incidence of this devastating illness could possibly be reduced by 50% with attentive primary care management. The cardiologist is often involved in the treatment of patients at risk for stroke, and is in an ideal position to provide this care.
引用
收藏
页码:393 / 403
页数:10
相关论文
共 50 条
  • [1] Ischemic stroke prevention
    Seemant Chaturvedi
    Susan Hickenbottom
    Steven R. Levine
    Current Treatment Options in Neurology, 1999, 1 (2) : 113 - 125
  • [2] Prevention of ischemic stroke
    Weinberger J.
    Current Cardiology Reports, 2002, 4 (2) : 164 - 171
  • [3] Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke
    Kapil, Nikhil
    Datta, Yvonne H.
    Alakbarova, Naila
    Bershad, Eric
    Selim, Magdy
    Liebeskind, David S.
    Bachour, Ornina
    Rao, Gundu H. R.
    Divani, Afshin A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (04) : 301 - 318
  • [4] Update on antithrombotic secondary prevention of ischemic stroke
    Koehrmann, Martin
    Kleinschnitz, Christoph
    NERVENARZT, 2019, 90 (10): : 995 - 1004
  • [5] Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis
    Wang, Wen
    Zhang, Lu
    Liu, Weiming
    Zhu, Qin
    Lan, Qing
    Zhao, Jizong
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05) : 1081 - 1089
  • [6] Combination antiplatelet agents for secondary prevention of ischemic stroke
    Griend, Joseph P. Vande
    Saseen, Joseph J.
    PHARMACOTHERAPY, 2008, 28 (10): : 1233 - 1242
  • [7] Acute Secondary Prevention of Ischemic Stroke: Overlooked No Longer
    Bulwa, Zachary B.
    Mendelson, Scott J.
    Brorson, James R.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Thomson, Ruth M.
    Anderson, David C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (02)
  • [9] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Ruth M. Thomson
    David C. Anderson
    Current Neurology and Neuroscience Reports, 2013, 13
  • [10] Choices in medical management for prevention of acute ischemic stroke.
    Fleck J.D.
    Biller J.
    Current Neurology and Neuroscience Reports, 2001, 1 (1) : 33 - 38